Question explored with the scientific record
How can endometriosis be treated? What measures can be taken to lessen its effects?
The short version: hormonal therapy helps about half of women with deep endometriosis, but surgery and diet are real options too, and the evidence quality varies sharply.
Endometriosis is treated along two tracks: hormones and surgery. In a London study of 152 women with deeply infiltrating disease, about 53 in 100 got symptom control from hormonal therapy alone, avoiding surgery [1]. The most common options were combined birth control pills, progestogens, the levonorgestrel IUD, and GnRH analogues [1]. GnRH agonists relieve pain in most users, but the effect often fades: about 43 in 100 kept relief six months after stopping, and only 33 in 100 at one year [3]. Newer oral GnRH antagonists like elagolix also work, with roughly 46 in 100 responding at a lower dose and 76 in 100 at a higher one [7]. These drugs suppress estrogen, so they carry real costs: hot flashes, bone density loss, mood changes [6].
Surgery is the other main route. Laparoscopic excision of endometriosis tissue gives better pain relief than simple cyst drainage, but it can permanently lower ovarian reserve, especially when both ovaries are involved [8][10]. One review found about 20 to 40 in 100 women have pain recurrence after conservative surgery, and 15 to 20 in 100 need another operation [9]. Adding hormone therapy after surgery did not clearly reduce recurrence in a meta-analysis of eight trials [4].
Diet and lifestyle matter, though the evidence is weaker. A 2025 Polish study of 200 women found that higher intake of whole-grain bread, fish, fruits, and eggs was linked to milder pain, while sugar and sweetened drinks tracked with more missed work [2]. A 2025 review lists pelvic floor physiotherapy, exercise, mindfulness, and low-FODMAP diets as emerging non-medical options [5]. These are observational findings, not proof.
| Treatment | Benefit | Key limitation |
|---|---|---|
| Hormonal therapy | ~53% symptom control in deep disease [1] | Effect fades after stopping [3] |
| GnRH agonists | 92% pain relief while on drug [3] | Bone loss, hot flashes [6] |
| Surgery (excision) | Better pain relief than drainage [8] | 20–40% recurrence [9]; lowers ovarian reserve [10] |
| Diet changes | Milder pain with whole grains, fish, fruit [2] | Observational only [2] |
The evidence base is thin in important ways. Most studies are observational or single-center, not large randomized trials with hard endpoints. No retrieved study compared treated women against a genuinely untreated group over years. The diet data is cross-sectional, so it cannot prove cause and effect [2]. For a condition that takes 7 to 9 years to diagnose on average [5], the lack of long-term comparative data is a real gap.
My call: hormonal therapy and excision surgery are the best-supported options, but both have meaningful trade-offs, and the diet evidence is suggestive, not proven. Confidence: moderate.
Sources used 10
-
Medical management of deeply infiltrating endometriosis - 7 year experience in a tertiary endometriosis centre in London
Approximately half of women with deeply infiltrating endometriosis achieved symptom control with hormonal therapy at a London tertiary endometriosis centre over seven years, potentially avoiding surgery.
DOI: 10.1186/s10397-019-1065-9 -
The Impact of Nutrition on Endometriosis Complaints in Patients Using and Not Using Hormone Therapy
This cross-sectional study in Poland assesses how diet and hormone therapy status relate to menstrual pain and functioning in 200 women with endometriosis, identifying distinct diet–symptom patterns between those using hormone therapy and those not using it.
DOI: 10.3390/nu17172889 -
Optimizing Gonadotropin-Releasing Hormone Agonist Therapy in Women with Endometriosis
This study reviews the optimization of Gonadotropin-Releasing Hormone (GnRH) agonist therapy for women with endometriosis, highlighting its efficacy in pain relief and the importance of proper administration to minimize adverse effects.
DOI: 10.2165/00024677-200403020-00003 -
Effectiveness of Conservative Surgery and Adjunctive Hormone Suppression Therapy versus Surgery Alone in the Treatment of Symptomatic Endometriosis: A Systematic Review with Meta-analysis
A systematic review and meta-analysis evaluating whether adding conservative post-surgical hormone suppression therapy to conservative surgery improves pelvic pain and disease recurrence compared with surgery alone in symptomatic endometriosis; overall no clear benefit was found…
DOI: 10.3329/bjms.v13i1.17377 -
Endometriosis: new insights and opportunities for relief of symptoms
This narrative review synthesizes current understanding of endometriosis as a multisystem inflammatory disorder, highlighting genetic/molecular insights, diagnostic challenges, and emerging medical, lifestyle, and non-medical therapies aimed at relieving symptoms and improving q…
DOI: 10.1093/biolre/ioaf164 -
Elagolix - a novel drug for management of endometriosis and uterine fibroids
Elagolix is an oral GnRH antagonist that rapidly suppresses ovarian hormones to treat endometriosis and fibroids, with dose-dependent efficacy for pain and heavy bleeding and add-back therapy to mitigate hypoestrogenic adverse effects.
DOI: 10.18203/2320-1770.ijrcog20252375 -
Efficacy of elagolix in the treatment of endometriosis
This study evaluates the efficacy and safety of elagolix, a novel oral GnRH antagonist, in treating endometriosis-associated pain through a review of multiple clinical trials.
DOI: 10.1080/14656566.2017.1359258 -
Pain and Fertility Outcomes in Patients Undergoing Cyst Excision Versus Cyst Aspiration in Moderate to Severe Endometriosis: A Case Series
This Indian case series compares pain relief and fertility outcomes after cyst excision versus cyst aspiration in women with moderate to severe endometriosis, finding cystectomy provides better pain relief but may reduce ovarian reserve, with similar overall fertility outcomes b…
DOI: 10.70135/seejph.vi.2212 -
Surgical Management of Endometriosis in Patients with Chronic Pelvic Pain
A comprehensive review of surgical management of endometriosis in patients with chronic pelvic pain, detailing conservative and definitive surgical options, their outcomes and risks, and postoperative medical strategies.
DOI: 10.1055/s-0036-1597306 -
The Impact of Endometriosis and Its Treatment on Ovarian Reserve
This review synthesizes evidence on how endometriosis, particularly ovarian endometriomas, and their surgical treatment affect ovarian reserve, showing reduced AMH and AFC with endometrioma, a further often permanent decline after cystectomy (especially in bilateral disease), an…
DOI: 10.1055/s-0035-1567820